Loading...
Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories
Hynds, R. E. Frese, Kristopher K Pearce, D. R. Grönroos, E. Dive, Caroline Swanton, C.
Hynds, R. E.
Frese, Kristopher K
Pearce, D. R.
Grönroos, E.
Dive, Caroline
Swanton, C.
Citations
Altmetric:
Abstract
Non-small-cell lung cancer (NSCLC) is the leading cause of cancer-related deaths worldwide. Although advances are being made towards earlier detection and the development of impactful targeted therapies and immunotherapies, the 5-year survival of patients with advanced disease is still below 20%. Effective cancer research relies on pre-clinical model systems that accurately reflect the evolutionary course of disease progression and mimic patient responses to therapy. Here, we review pre-clinical models, including genetically engineered mouse models and patient-derived materials, such as cell lines, primary cell cultures, explant cultures and xenografts, that are currently being used to interrogate NSCLC evolution from pre-invasive disease through locally invasive cancer to the metastatic colonization of distant organ sites.
Description
Date
2021
Publisher
Collections
Files
Loading...
From UNPAYWALL
Adobe PDF, 697.4 KB
Keywords
Type
Article
Citation
Hynds RE, Frese KK, Pearce DR, Gronroos E, Dive C, Swanton C. Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories. Open Biol. 2021;11(1):200247.